BACK - IMAC Holdings, Inc. Real Price to Acquire Entire Company

Graphic logo of IMAC Corp (BACK)

IMAC Holdings, Inc. (BACK) operates a network of restorative therapy centers, where stable demand for physiotherapy and insurance payouts support high margins and cash flow. The business generates revenue through regenerative medicine and joint treatment at its own clinics. This price chart illustrating trading dynamics shows an Enterprise Value of , while operating exclusively in the US market provides the company with full immunity to global political risks.

BACK imacholdings.comm: Real Price to Acquire Entire Company in the range 07/04/2022 - 10/29/2026
Brand item of IMAC Regeneration Centers

The US domestic market shields IMAC Holdings, Inc. (BACK) clinics from sanctions, yet inflationary pressure on operating expenses necessitates monitoring the business's real value. By analyzing the projected enterprise value (market capitalization plus net debt), an investor can determine the actual acquisition price of the asset, where the chart's price action allows for the rapid identification of bankruptcy risks or potential undervaluation during periods of infrequent reporting.

Competitor analysis for IMAC Holdings, Inc.

Enterprise Value HCA Inc. HCA|Tenet - Enterprise Value|Fresenius Medical (FMS) - Real Price to Acquire Entire Company|Solventum Corporation (SOLV) - Total Company Value|encompasshealth.com (EHC) - Enterprise Value|Real Price to Acquire Entire Company UHS|DVA (DaVita HealthCare Partners) - Aggregate Business Value|Total Company Value RadNet Corp (RDNT)|OPCH (Option Care Corp) - Value Adjusted for Debt and Cash|Enterprise Value SGRY (Surgery Partners, Inc.)|premierinc.com (PINC) - Total Enterprise Value|National Vision - Enterprise Value|PGNY - Enterprise Value|ARDT (Ardent Health Partners Inc) - Real Price to Acquire Entire Company|SEM: Aggregate Business Value|Total Company Value Astrana Health, Inc.|Real Price to Acquire Entire Company MEDNAX (MD)|Enterprise Value USPH|PNTG - Total Enterprise Value|Total Company Value Organogenesis Inc. ORGO|NUTX: Business Value|AUNA: Real Price to Acquire Entire Company|SBC Medical Group Holdings - Aggregate Business Value|EOLS: Enterprise Value|CYH - Company Buyout Price|Total Company Value The Beauty Health Company|Real Price to Acquire Entire Company MediWound, Ltd. (MDWD)|Enterprise Value BTMD|Enterprise Value thejoint.com (JYNT)|Enterprise Value DCGO (DocGo)|PIII - Real Price to Acquire Entire Company|GANX: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash EUDA (EUDA Health Holdings)|BMGL: Enterprise Value|CollPlant Biotechnologies Ltd. - Value Adjusted for Debt and Cash|Total Company Value Cuprina Holdings|Total Enterprise Value Concord Medical Services Holdings CCM|Total Company Value American Shared Hospital Services, Inc. (AMS)|Total Company Value MRM (MEDIROM Corp)|Enterprise Value ALBT (Avalon GloboCare Corp.)|DHAI: Business Value|Carmell Therapeutics - Enterprise Value|Company Buyout Price NewGenIvf Group NIVF|atipt.com (ATIP) - Total Company Value|Business Value CMAX|KDLY (Kindly MD, Inc.) - Enterprise Value|MODV - Full Takeover Company Value|Total Company Value Novo Integrated Sciences, Inc. (NVOS)|Company Buyout Price sunlinkhealth.com